Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-EN Version v4-FR
Language English French
Date Updated 2022-10-01 2022-09-02
Drug Identification Number 00781878 00781878
Brand name VITAMIN K1 INJ 1MG/0.5ML USP VITAMIN K1 INJ 1MG/0.5ML USP
Common or Proper name VITAMIN K1 VITAMIN K1
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients VITAMIN K1 VITAMIN K1
Strength(s) 2MG 2MG
Dosage form(s) EMULSION EMULSION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 0.5ML 10LIAM 0.5ML 10LIAM
ATC code B02BA B02BA
ATC description VITAMIN K AND OTHER HEMOSTATICS VITAMIN K AND OTHER HEMOSTATICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-09-02 2022-09-02
Estimated end date 2022-09-30 Unknown
Actual end date 2022-09-30
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Baxter item : 9100 Baxter item : 9100
Health Canada comments